The North America Leadless Pacemakers Market would witness market growth of 14.2% CAGR during the forecast period (2023-2030).
In terms of innovation, the market is moving towards the development of leadless pacemakers with magnetic resonance imaging (MRI) compatibility. This innovation opens up new possibilities for patients who may require MRI scans, as traditional pacemakers are generally not MRI-compatible due to potential safety concerns. Leadless pacemakers that can safely undergo MRI procedures offer enhanced flexibility in diagnostic imaging for patients who need cardiac pacing and radiological assessments.
The market has also seen the emergence of bioabsorbable leadless devices. These devices are designed to dissolve within the body once their function is no longer required. While still in the early stages of development and testing, bioabsorbable leadless pacemakers represent an exciting avenue of research, with the potential to further reduce the long-term impact of cardiac pacing on a patient's body.
Moreover, advancements in telemedicine and remote monitoring technologies have significantly impacted the market. These technologies enable healthcare providers to remotely monitor patients' cardiac data, enabling early detection of issues and timely interventions. The convenience and peace of mind offered by remote monitoring are particularly appealing to patients, further driving the adoption of leadless pacemakers.
According to the Canadian Cardiovascular Society, as many as a million Canadians live with atrial fibrillation, an irregular rhythm or rapid heart rate. This growing epidemic can lead to days of lost work, extensive and disabling strokes, heart failure, anxiety, depression, and reduced life expectancy. Moreover, according to the National Library of Medicine, the prevalence of AF is nearly 2% in the general population; in Mexico, more than one-half million people are affected.
Moreover, obesity has emerged as an epidemic in North America, significantly impacting the prevalence of AF. A substantial portion of the population in the region grapples with issues related to being overweight or obese. This excess weight is intricately linked to structural changes in the heart and electrical abnormalities, which serve as prominent risk factors for AF development. Therefore, the prevalence of AF in North America reflects a complex interplay of demographic shifts, lifestyle choices, genetic factors, and improvements in healthcare access and diagnosis, driving the demand for leadless pacemakers.
The US market dominated the North America Leadless Pacemakers Market, By Country in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $275,371.2 Thousands by 2030. The Canada market is exhibiting a CAGR of 16.7% during (2023 - 2030). Additionally, The Mexico market would experience a CAGR of 15.7% during (2023 - 2030).
Based on Type, the market is segmented into Micra Transcatheter Pacing System, and Others. Based on End-use, the market is segmented into Hospitals, and Outpatient Facilities. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
Free Valuable Insights: The Leadless Pacemakers Market is Predict to reach $827.7 Million by 2030, at a CAGR of 15.2%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Medtronic PLC, Abbott Laboratories, Boston Scientific Corporation, Biotronik SE & Co. KG, Lepu Medical Technology Co., Ltd, Integer Holdings Corporation, MicroPort Scientific Corporation, Osypka AG, Terumo Corporation, and EBR Systems, Inc.
Scope of the Study
Market Segments Covered in the Report:
By Type
- Micra Transcatheter Pacing System
- Others
By End-use
- Hospitals
- Outpatient Facilities
By Country
- US
- Canada
- Mexico
- Rest of North America
Key Market Players
List of Companies Profiled in the Report:
- Medtronic PLC
- Abbott Laboratories
- Boston Scientific Corporation
- Biotronik SE & Co. KG
- Lepu Medical Technology Co., Ltd
- Integer Holdings Corporation
- MicroPort Scientific Corporation
- Osypka AG
- Terumo Corporation
- EBR Systems, Inc.
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Leadless Pacemakers Market, by Type
1.4.2 North America Leadless Pacemakers Market, by End-use
1.4.3 North America Leadless Pacemakers Market, by Country
1.5 Methodology for the research
Chapter 2. Market at a Glance
2.1 Key Highlights
Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Restraints
Chapter 4. Competition Analysis - Global
4.1 KBV Cardinal Matrix
4.2 Recent Industry Wide Strategic Developments
4.2.1 Partnerships, Collaborations and Agreements
4.2.2 Product Launches and Product Expansions
4.2.3 Acquisition and Mergers
4.2.4 Trials & Approvals
4.3 Top Winning Strategies
4.3.1 Key Leading Strategies: Percentage Distribution (2019-2023)
4.3.2 Key Strategic Move: (Mergers & Acquisition: 2019, Nov – 2023, Sep) Leading Players
4.4 Porter’s Five Forces Analysis
Chapter 5. North America Leadless Pacemakers Market, By Type
5.1 North America Micra Transcatheter Pacing System Market, By Country
5.2 North America Others Market, By Country
Chapter 6. North America Leadless Pacemakers Market, By End-use
6.1 North America Hospitals Market, By Country
6.2 North America Outpatient Facilities Market, By Country
Chapter 7. North America Leadless Pacemakers Market, By Country
7.1 US Leadless Pacemakers Market
7.1.1 US Leadless Pacemakers Market, By Type
7.1.2 US Leadless Pacemakers Market, By End-use
7.2 Canada Leadless Pacemakers Market
7.2.1 Canada Leadless Pacemakers Market, By Type
7.2.2 Canada Leadless Pacemakers Market, By End-use
7.3 Mexico Leadless Pacemakers Market
7.3.1 Mexico Leadless Pacemakers Market, By Type
7.3.2 Mexico Leadless Pacemakers Market, By End-use
7.4 Rest of North America Leadless Pacemakers Market
7.4.1 Rest of North America Leadless Pacemakers Market, By Type
7.4.2 Rest of North America Leadless Pacemakers Market, By End-use
Chapter 8. Company Profiles
8.1 Medtronic PLC
8.1.1 Company overview
8.1.2 Financial Analysis
8.1.3 Segmental and Regional Analysis
8.1.4 Research & Development Expenses
8.1.5 Recent strategies and developments:
8.1.5.1 Partnerships, Collaborations, and Agreements:
8.1.5.2 Product Launches and Product Expansions:
8.1.5.3 Acquisition and Mergers:
8.1.5.4 Geographical Expansions:
8.1.6 SWOT Analysis
8.2 Abbott Laboratories
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Segmental and Regional Analysis
8.2.4 Research & Development Expense
8.2.5 Recent strategies and developments:
8.2.5.1 Product Launches and Product Expansions:
8.2.5.2 Acquisition and Mergers:
8.2.6 SWOT Analysis
8.3 Boston Scientific Corporation
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Segmental and Regional Analysis
8.3.4 Research & Development Expense
8.3.5 Recent strategies and developments:
8.3.5.1 Partnerships, Collaborations, and Agreements:
8.3.5.2 Product Launches and Product Expansions:
8.3.5.3 Acquisition and Mergers:
8.3.5.4 Trials & Approval:
8.3.6 SWOT Analysis
8.4 Biotronik SE & Co. KG
8.4.1 Company Overview
8.4.2 Recent strategies and developments:
8.4.2.1 Trials & Approval:
8.4.3 SWOT Analysis
8.5 Lepu Medical Technology Co., Ltd
8.5.1 Company Overview
8.5.2 SWOT Analysis
8.6 Integer Holdings Corporation
8.6.1 Company Overview
8.6.2 Financial Analysis
8.6.3 Segmental and Regional Analysis
8.6.4 Research & Development Expenses
8.6.5 SWOT Analysis
8.7 MicroPort Scientific Corporation
8.7.1 Company Overview
8.7.2 Financial Analysis
8.7.3 Segmental and Regional Analysis
8.7.4 Research & Development Expense
8.7.5 SWOT Analysis
8.8 OSYPKA AG
8.8.1 Company Overview
8.8.2 SWOT Analysis
8.9 Terumo Corporation
8.9.1 Company Overview
8.9.2 Financial Analysis
8.9.3 Segmental and Regional Analysis
8.9.4 Research & Development Expenses
8.9.5 Recent strategies and developments:
8.9.5.1 Partnerships, Collaborations, and Agreements:
8.9.5.2 Acquisition and Mergers:
8.9.6 SWOT Analysis
8.10. EBR Systems, Inc.
8.10.1 Company Overview
8.10.2 SWOT Analysis
TABLE 1 North America Leadless Pacemakers Market, 2019 - 2022, USD Thousands
TABLE 2 North America Leadless Pacemakers Market, 2023 - 2030, USD Thousands
TABLE 3 Partnerships, Collaborations and Agreements– Leadless Pacemakers Market
TABLE 4 Product Launches And Product Expansions– Leadless Pacemakers Market
TABLE 5 Acquisition and Mergers– Leadless Pacemakers Market
TABLE 6 Trials & Approvals– Leadless Pacemakers Market
TABLE 7 North America Leadless Pacemakers Market, By Type, 2019 - 2022, USD Thousands
TABLE 8 North America Leadless Pacemakers Market, By Type, 2023 - 2030, USD Thousands
TABLE 9 North America Micra Transcatheter Pacing System Market, By Country, 2019 - 2022, USD Thousands
TABLE 10 North America Micra Transcatheter Pacing System Market, By Country, 2023 - 2030, USD Thousands
TABLE 11 North America Others Market, By Country, 2019 - 2022, USD Thousands
TABLE 12 North America Others Market, By Country, 2023 - 2030, USD Thousands
TABLE 13 North America Leadless Pacemakers Market, By End-use, 2019 - 2022, USD Thousands
TABLE 14 North America Leadless Pacemakers Market, By End-use, 2023 - 2030, USD Thousands
TABLE 15 North America Hospitals Market, By Country, 2019 - 2022, USD Thousands
TABLE 16 North America Hospitals Market, By Country, 2023 - 2030, USD Thousands
TABLE 17 North America Outpatient Facilities Market, By Country, 2019 - 2022, USD Thousands
TABLE 18 North America Outpatient Facilities Market, By Country, 2023 - 2030, USD Thousands
TABLE 19 North America Leadless Pacemakers Market, By Country, 2019 - 2022, USD Thousands
TABLE 20 North America Leadless Pacemakers Market, By Country, 2023 - 2030, USD Thousands
TABLE 21 US Leadless Pacemakers Market, 2019 - 2022, USD Thousands
TABLE 22 US Leadless Pacemakers Market, 2023 - 2030, USD Thousands
TABLE 23 US Leadless Pacemakers Market, By Type, 2019 - 2022, USD Thousands
TABLE 24 US Leadless Pacemakers Market, By Type, 2023 - 2030, USD Thousands
TABLE 25 US Leadless Pacemakers Market, By End-use, 2019 - 2022, USD Thousands
TABLE 26 US Leadless Pacemakers Market, By End-use, 2023 - 2030, USD Thousands
TABLE 27 Canada Leadless Pacemakers Market, 2019 - 2022, USD Thousands
TABLE 28 Canada Leadless Pacemakers Market, 2023 - 2030, USD Thousands
TABLE 29 Canada Leadless Pacemakers Market, By Type, 2019 - 2022, USD Thousands
TABLE 30 Canada Leadless Pacemakers Market, By Type, 2023 - 2030, USD Thousands
TABLE 31 Canada Leadless Pacemakers Market, By End-use, 2019 - 2022, USD Thousands
TABLE 32 Canada Leadless Pacemakers Market, By End-use, 2023 - 2030, USD Thousands
TABLE 33 Mexico Leadless Pacemakers Market, 2019 - 2022, USD Thousands
TABLE 34 Mexico Leadless Pacemakers Market, 2023 - 2030, USD Thousands
TABLE 35 Mexico Leadless Pacemakers Market, By Type, 2019 - 2022, USD Thousands
TABLE 36 Mexico Leadless Pacemakers Market, By Type, 2023 - 2030, USD Thousands
TABLE 37 Mexico Leadless Pacemakers Market, By End-use, 2019 - 2022, USD Thousands
TABLE 38 Mexico Leadless Pacemakers Market, By End-use, 2023 - 2030, USD Thousands
TABLE 39 Rest of North America Leadless Pacemakers Market, 2019 - 2022, USD Thousands
TABLE 40 Rest of North America Leadless Pacemakers Market, 2023 - 2030, USD Thousands
TABLE 41 Rest of North America Leadless Pacemakers Market, By Type, 2019 - 2022, USD Thousands
TABLE 42 Rest of North America Leadless Pacemakers Market, By Type, 2023 - 2030, USD Thousands
TABLE 43 Rest of North America Leadless Pacemakers Market, By End-use, 2019 - 2022, USD Thousands
TABLE 44 Rest of North America Leadless Pacemakers Market, By End-use, 2023 - 2030, USD Thousands
TABLE 45 Key Information – Medtronic PLC
TABLE 46 Key Information – Abbott Laboratories
TABLE 47 Key Information – Boston Scientific Corporation
TABLE 48 Key Information – Biotronik SE & Co. KG
TABLE 49 Key Information – Lepu Medical Technology Co., Ltd
TABLE 50 Key Information – Integer Holdings Corporation
TABLE 51 key Information – MicroPort Scientific Corporation
TABLE 52 Key Information – OSYPKA AG
TABLE 53 Key Information – Terumo Corporation
TABLE 54 Key Information – EBR Systems, Inc.
List of Figures
FIG 1 Methodology for the research
FIG 2 North America Leadless Pacemakers Market, 2019 - 2030, USD Thousands
FIG 3 Key Factors Impacting the Leadless Pacemakers Market
FIG 4 KBV Cardinal Matrix
FIG 5 Key Leading Strategies: Percentage Distribution (2019-2023)
FIG 6 Key Strategic Move: (Mergers & Acquisition: 2019, Nov – 2023, Sep) Leading Players
FIG 7 Porter’s Five Forces Analysis - Leadless Pacemakers Market
FIG 8 North America Leadless Pacemakers Market share, By Type, 2022
FIG 9 North America Leadless Pacemakers Market share, By Type, 2030
FIG 10 North America Leadless Pacemakers Market, By Type, 2019 - 2030, USD Thousands
FIG 11 North America Leadless Pacemakers Market share, By End-use, 2022
FIG 12 North America Leadless Pacemakers Market share, By End-use, 2030
FIG 13 North America Leadless Pacemakers Market, By End-use, 2019 - 2030, USD Thousands
FIG 14 North America Leadless Pacemakers Market share, By Country, 2022
FIG 15 North America Leadless Pacemakers Market share, By Country, 2030
FIG 16 North America Leadless Pacemakers Market, By Country, 2019 - 2030, USD Thousands
FIG 17 Recent strategies and developments: Medtronic PLC
FIG 18 SWOT Analysis: Medtronic PLC
FIG 19 Recent strategies and developments: Abbott Laboratories
FIG 20 SWOT Analysis: Abbott Laboratories
FIG 21 Recent strategies and developments: Boston Scientific Corporation
FIG 22 SWOT Analysis: Boston Scientific Corporation
FIG 23 SWOT Analysis: Biotronik SE & Co. KG
FIG 24 SWOT Analysis: Lepu Medical Technology Co., Ltd
FIG 25 SWOT Analysis: Integer Holdings Corporation
FIG 26 SWOT Analysis: MicroPort Scientific Corporation
FIG 27 SWOT Analysis: OSYPKA AG
FIG 28 Recent strategies and developments: Terumo Corporation
FIG 29 SWOT Analysis: Terumo Corporation
FIG 30 SWOT Analysis: EBR Systems, Inc.